Mass drug administration against malaria seen effective
Over the subsequent nine months, P. falciparum infections returned but stayed well below baseline levels, the study said.The emergence and spread of multidrug-resistant P. falciparum in the Greater Mekong sub-region threatens global malaria elimination efforts.
“A good investment, in my mind.”“This [falciparum] is the most dangerous form of malaria; in the Greater Mekong sub-region, it is becoming resistant to many types of anti-malarial drugs,” Gosling says.
“Even if it costs more, it can save money in the future by stopping drug-resistant malaria spreading elsewhere in the world.“This [falciparum] is the most dangerous form of malaria; in the Greater Mekong sub-region, it is becoming resistant to many types of antimalarial drugs,” Gosling says.
P. falciparum accounted for 97 per cent of the deaths in Africa, 71.9 per cent for both the Western Pacific and the Eastern Mediterranean, and 62.8 per cent in South-East Asia.Elimination of malaria in a defined geographical area depends on the interruption of local transmission (reduction to zero incidence of indigenous cases) of a specified malaria parasite species, says WHO.
The result was published February in the journal PLoS Medicine.By the third month of administrating the anti-malaria drugs dihydroartemisinin-piperaquine and low-dose primaquine, the prevalence of P. falciparum had decreased by 92 per cent in villages where MDA had been carried out.